Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of Potential Therapeutics for Infantile Hemangioma via in silico Investigation and in vitro Validation

1 Sept 2024

Abstract excerpt

Introduction: Infantile Hemangioma (IH) is a prevalent benign vascular tumor affecting approximately 5– 10% of infants. Its underlying pathogenesis remains enigmatic, and current therapeutic approaches show limited effectiveness. Our study aimed to discover potential IH-associated therapeutics through a transcriptomic, computational drug repurposing methodology. Methods: Utilizing the IH-specific dataset...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer, Hypoxia, and Metabolism
Share to Vascular Malformations and Hemangiomas
Share to Vascular Tumors and Angiosarcomas

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39286286
DOI: 10.2147/dddt.s460575

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of Potential Therapeutics for Infantile Hemangioma via in silico Investigation and in vitro ValidationPMID 39286286Read ↗

Integrative meta-analysis identifies microRNA-regulated networks in infantile hemangiomaSemantic proximity Read ↗

Infantile Hemangioma Originates From A Dysregulated But Not Fully Transformed Multipotent Stem CellSemantic proximity Read ↗

LncRNA-TUG1 promotes the progression of infantile hemangioma by regulating miR-137/IGFBP5 axis.Semantic proximity Read ↗

CircAP2A2 acts as a ceRNA to participate in infantile hemangiomas progression by sponging miR‐382‐5p via regulating the expression of VEGFASemantic proximity Read ↗

New and Emerging Targeted Therapies for Vascular Malformations.Semantic proximity Read ↗

Targeted treatments for vascular malformations: current state of the art.Semantic proximity Read ↗

An endothelial SOX18-mevalonate pathway axis enables repurposing of statins for infantile hemangiomaSemantic proximity Read ↗

Development of Molecular Therapies for Venous Malformations.Semantic proximity Read ↗

Novel organoid construction strategy for non-involuting congenital hemangioma for drug validationSemantic proximity Read ↗

Infantile hemangioma: the common and enigmatic vascular tumorSemantic proximity Read ↗

Circular RNA hsa_circ_0000915 promotes propranolol resistance of hemangioma stem cells in infantile haemangiomasSemantic proximity Read ↗

Endothelial and circulating C19MC microRNAs are biomarkers of infantile hemangiomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.